[HTML][HTML] Therapeutic advances of miRNAs: A preclinical and clinical update

C Chakraborty, AR Sharma, G Sharma… - Journal of advanced …, 2021 - Elsevier
Background miRNAs, a class of small endogenous RNAs, are one of the essential
biopharmaceuticals which are in commercial spans as next-generation medicine in recent …

MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies

T Kim, CM Croce - Experimental & molecular medicine, 2023 - nature.com
As a type of short noncoding RNAs, microRNA (miRNA) undoubtedly plays a crucial role in
cancer development. Since the discovery of the identity and clinical functions of miRNAs …

Genetic, environmental, and epigenetic factors involved in CAKUT

N Nicolaou, KY Renkema, EMHF Bongers… - Nature Reviews …, 2015 - nature.com
Congenital anomalies of the kidney and urinary tract (CAKUT) refer to a spectrum of
structural renal malformations and are the leading cause of end-stage renal disease in …

MicroRNAs in kidney physiology and disease

P Trionfini, A Benigni, G Remuzzi - Nature Reviews Nephrology, 2015 - nature.com
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene expression.
They have important roles during kidney development, homeostasis and disease. In …

An ensemble of deep neural networks for kidney ultrasound image classification

S Sudharson, P Kokil - Computer Methods and Programs in Biomedicine, 2020 - Elsevier
Background and objective: Chronic kidney disease is a worldwide health issue which
includes not only kidney failure but also complications of reduced kidney functionality. Cyst …

Discovery and preclinical evaluation of anti-miR-17 oligonucleotide RGLS4326 for the treatment of polycystic kidney disease

EC Lee, T Valencia, C Allerson, A Schairer… - Nature …, 2019 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD), caused by mutations in either
PKD1 or PKD2 genes, is one of the most common human monogenetic disorders and the …

[HTML][HTML] microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism

S Hajarnis, R Lakhia, M Yheskel, D Williams… - Nature …, 2017 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause
of renal failure. Here we identify miR-17 as a target for the treatment of ADPKD. We report …

[图书][B] Mammalian transient receptor potential (TRP) cation channels

B Nilius, V Flockerzi - 2014 - Springer
When we edited in 2007 the first issue on transient receptor potential channel in the
Handbook of Experimental Pharmacology, we were all very excited by the progress in this …

PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression

R Lakhia, H Ramalingam, CM Chang… - Nature …, 2022 - nature.com
Autosomal dominant polycystic kidney disease (ADPKD), among the most common human
genetic conditions and a frequent etiology of kidney failure, is primarily caused by …

Autosomal dominant polycystic kidney disease: from pathophysiology of cystogenesis to advances in the treatment

J Reiterová, V Tesař - International Journal of Molecular Sciences, 2022 - mdpi.com
Autosomal dominant polycystic kidney disease (ADPKD) is the most common genetic renal
disease, with an estimated prevalence between 1: 1000 and 1: 2500. It is mostly caused by …